Mechanism of osteoclastogenesis inhibitory action by interleukin 18
Mechanism of osteoclastogenesis inhibitory action by interleukin 18
批准号:
09671905
负责人:
UDAGAWA Nobuyuki
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
IL-18在体外抑制破骨细胞(CCL)的形成,不依赖于干扰素-γ的产生,这种抑制作用可被GM-CSF的中和抗体所取消。我们现在发现,在GM-CSF缺陷小鼠(GM-CSF-/-)的共同培养中,IL-18不能抑制CCL的形成。用野生型成骨细胞与GM-CSF-/-脾细胞或GM-CSF-/-成骨细胞与野生型脾细胞相互共培养。野生型脾细胞被要求对IL-18产生反应,这表明脾来源的细胞是IL-18的靶标。由于T细胞在脾细胞群中占很大比例,因此对T细胞在破骨细胞形成中的作用进行了研究。全部T细胞被取出,并以不同的组合重新加入。在GM-CSF-/-共培养中加入野生型T细胞可恢复IL-18对破骨细胞生成的抑制作用。T细胞的主要亚群0D4和CD8^也分别被耗尽。加入CD4^或CD8^野生型T细胞可在GM-CSF-/-背景下恢复IL-18的活性,而当加入CD4^或CD8^GM-CSF-/-T细胞时,IL-18则无效。这些结果突出了T细胞参与了IL-18诱导的CCL抑制,并为IL-18通过作用于T细胞促进GM-CSF的释放进而作用于CCL前体而抑制CCL的形成提供了新的证据。
英文摘要
IL-18 inhibits osteoclast (CCL) formation in vitro independent of IFN-gamma production, and this was abolished by the addition of neutralizing antibodies to GM-CSF.We now establish that IL-18 was unable to inhibit CCL formation in cocultures using GM-CSF-deficient mice (GM-CSF-/-). Reciprocal cocultures using either wild-type osteoblasts with GM-CSF -/- spleen cells or GM-CSF -/- osteoblasts with wild-type spleen cells were examined. Wild-type spleen cells were required to elicit a response to IL-18 indicating that cells of splenic origin were the IL-18 target. As T cells comprise a large proportion of the spleen cell population, the role of T cells in osteoclastogenesis was examined. Total T cells were removed and repleted in various combinations. Addition of wild-type T cells to a GM-CSF -/- coculture restored IL-18 inhibition of osteoclastogenesis. Major subsets of T cells, 0D4 and CD8+^+, were also individually depleted. Addition of either CD4^+ or CD8^+ wild-type T cells restored IL-18 action in a GM-CSF -/- background, while IL-18 was ineffective when either CD4^+ or CD8^+ GM-CSF -/- T cells were added to a wild-type coculture. These results highlight the involvement of T cells in IL-18-induced CCL inhibition and provide evidence for a new CCL inhibitory pathway whereby IL-18 inhibits CCL formation due to action upon T cells promoting the release of GM-CSF, which in turn acts upon CCL precursors.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Katayama,Y.,et al.: "Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts." J.Cell.Physiol.176. 179-187 (1998)
Katayama, Y., et al.:“重组大鼠骨桥蛋白的酪蛋白激酶 2 磷酸化可增强破骨细胞的粘附,但不会增强成骨细胞的粘附。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakamura,I.,et al.: "Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice." FEBS Lett.401. 207-212 (1997)
Nakamura,I.,et al.:“骨硬化 (oc/oc) 小鼠破骨细胞中缺乏与细胞骨架相关的液泡质子 ATP 酶。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Udagawa, N., et al.: "Interleukin-18(interfero-γ-inducing factor)is produced by osteoblasts and acts via granulocyte/macrophage-colony stimulating factor and not via interferon-γ to inhibit osteoclast formation." J.Exp.Med.185. 1005-1012 (1997)
Udakawa, N. 等人:“Interleukin-18(干扰素 γ 诱导因子)由成骨细胞产生,通过粒细胞/巨噬细胞集落刺激因子而不是干扰素 γ 抑制破骨细胞形成。” .医学185.1005-1012(1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsurukai,T.,et al.: "Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time." J.Cell.Physiol.177. 26-35 (1998)
Tsurukai,T.,et al.:“破骨细胞前体的分离和表征,这些前体在短时间内在颅骨细胞上分化为破骨细胞。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuzaki, K., et al.: "Osteoclast differentiation factor(ODF)induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures." Biochem.Biophys.Res.Commun.246. 199-204 (1998)
Matsuzaki, K. 等人:“破骨细胞分化因子 (ODF) 在人外周血单核细胞培养物中诱导破骨细胞样细胞形成。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Exploration of seeds for development of a new drug targeting Bone-Vascular-Spleen axis
-
批准号:25670793
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Analysis of bone remodeling mechanism between osteoblasts and osteoclasts for the alveolar bone regeneration
-
批准号:24390417
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2012
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Basic research on development of new treatment of alveolar bone regeneration
-
批准号:21390498
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2009
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Elucidation of the regulated mechanism of bone metabolism by osteoclastic transcytosis.
-
批准号:19390476
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2007
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Establishment of periodontitis treatment method by inhibition of RANK-Toll like receptor signal
-
批准号:17390497
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.98万
-
财政年份:2005
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Signal transduction of RANK and Toll-like receptor in alveolar bone destruction
-
批准号:15390565
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2003
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
Analysis of signal transduction of osteoclast differentiation factor (RANKL) in alveolar bone destruction
-
批准号:13470394
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2001
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
The physiological role of osteoclast differentiation factor.
-
批准号:11470393
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.65万
-
财政年份:1999
-
负责人:UDAGAWA Nobuyuki
-
依托单位:
海外基金